Comprehensive Income (Loss), Net of Tax, Attributable to Parent of LB PHARMACEUTICALS INC from 30 Sep 2024 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary
LB PHARMACEUTICALS INC quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD history and change rate from 30 Sep 2024 to 30 Sep 2025.
  • LB PHARMACEUTICALS INC Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending 30 Sep 2025 was $3,609,000, a 75% increase year-over-year.
Source SEC data
View on sec.gov
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Change (%)

LB PHARMACEUTICALS INC Quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $3,609,000 +$10,890,000 +75% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $14,499,000 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.